Ontology list
Cellular componentmicro-ribonucleoprotein complex - GO:0035068; extracellular exosome - GO:0070062; cytoplasm - GO:0005737; extracellular space - GO:0005615;
Molecular functionmRNA binding involved in posttranscriptional gene silencing - GO:1903231; mRNA 3'-UTR binding - GO:0003730;
Biological processphenotypic switching - GO:0036166; regulation of cell shape - GO:0008360; positive regulation of potassium ion export across plasma membrane - GO:1903766; positive regulation of cellular response to hypoxia - GO:1900039; positive regulation of phosphatidylinositol 3-kinase signaling - GO:0014068; negative regulation of arginine catabolic process - GO:1900082; negative regulation of GTPase activity - GO:0034260; negative regulation of G1/S transition of mitotic cell cycle - GO:2000134; positive regulation of gene expression - GO:0010628; positive regulation of fat cell differentiation - GO:0045600; positive regulation of cell proliferation - GO:0008284; cellular response to resveratrol - GO:1904639; positive regulation of T-helper 17 type immune response - GO:2000318; positive regulation of endothelial cell migration - GO:0010595; negative regulation of smooth muscle cell apoptotic process - GO:0034392; negative regulation of cell proliferation - GO:0008285; positive regulation of vascular smooth muscle contraction - GO:1904695; positive regulation of protein phosphorylation - GO:0001934; negative regulation of innate immune response - GO:0045824; gene silencing by miRNA - GO:0035195; positive regulation of osteoblast differentiation - GO:0045669; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator - GO:1902254; activation of protein kinase B activity - GO:0032148; BMP signaling pathway - GO:0030509; positive regulation of leukocyte adhesion to vascular endothelial cell - GO:1904996; negative regulation of regulatory T cell differentiation - GO:0045590; negative regulation of type I interferon-mediated signaling pathway - GO:0060339; positive regulation of myofibroblast differentiation - GO:1904762; positive regulation of apoptotic process - GO:0043065; negative regulation of stress fiber assembly - GO:0051497; negative regulation of hydrogen peroxide-mediated programmed cell death - GO:1901299; negative regulation of MAPK cascade - GO:0043409; negative regulation of vascular associated smooth muscle cell apoptotic process - GO:1905460; regulation of epidermal growth factor receptor signaling pathway - GO:0042058; positive regulation of T-helper 17 cell differentiation - GO:2000321; negative regulation of angiogenesis - GO:0016525; positive regulation of vascular smooth muscle cell differentiation - GO:1905065; collagen metabolic process - GO:0032963; cellular response to lipopolysaccharide - GO:0071222; negative regulation of cardiac muscle hypertrophy - GO:0010614; positive regulation of replicative senescence - GO:1904728; negative regulation of ERK1 and ERK2 cascade - GO:0070373; negative regulation of cartilage development - GO:0061037; negative regulation of cell migration - GO:0030336; endothelial tube morphogenesis - GO:0061154; negative regulation of apoptotic process - GO:0043066; positive regulation of cardiac muscle hypertrophy - GO:0010613; positive regulation of vascular associated smooth muscle cell migration - GO:1904754; positive regulation of inflammatory response - GO:0050729; embryo implantation - GO:0007566; positive regulation of vascular smooth muscle cell proliferation - GO:1904707; negative regulation of hydrogen sulfide biosynthetic process - GO:1904827; positive regulation of cell migration - GO:0030335; transforming growth factor beta receptor signaling pathway - GO:0007179; positive regulation of cell projection organization - GO:0031346; negative regulation of chondrocyte proliferation - GO:1902731; positive regulation of angiogenesis - GO:0045766; miRNA mediated inhibition of translation - GO:0035278; negative regulation of endothelial cell migration - GO:0010596; negative regulation of vascular associated smooth muscle cell migration - GO:1904753; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint - GO:1902504; negative regulation of reactive oxygen species biosynthetic process - GO:1903427; negative regulation of endothelial tube morphogenesis - GO:1905955; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel - GO:1902514; regulation of cell migration - GO:0030334; positive regulation of cytokine production involved in inflammatory response - GO:1900017; negative regulation of type I interferon production - GO:0032480; positive regulation of vascular endothelial cell proliferation - GO:1905564; epithelial to mesenchymal transition involved in cardiac fibroblast development - GO:0060940; positive regulation of keratinocyte proliferation - GO:0010838; regulation of reactive oxygen species metabolic process - GO:2000377; positive regulation of activated T cell proliferation - GO:0042104; positive regulation of endothelial cell differentiation - GO:0045603; negative regulation of superoxide dismutase activity - GO:1901670; negative regulation of aortic smooth muscle cell differentiation - GO:1904830; negative regulation of cardiac muscle cell apoptotic process - GO:0010667; positive regulation of ERK1 and ERK2 cascade - GO:0070374; positive regulation of metalloendopeptidase activity - GO:1904685; positive regulation of epithelial to mesenchymal transition - GO:0010718; negative regulation of NIK/NF-kappaB signaling - GO:1901223; negative regulation of gene expression - GO:0010629; regulation of protein kinase B signaling - GO:0051896; positive regulation of protein kinase B signaling - GO:0051897; negative regulation of endothelial cell proliferation - GO:0001937;